Philip Morris International buys 22.6% stake in Vectura

US tobacco giant Philip Morris International (PMI) has purchased a 22.6% stake in respiratory drug company Vectura. Vectura’s board has backed PMI’s £1.1bn takeover bid; however, the move has sparked concern among health charities and public health experts who claim it could damage Vectura’s position in the medical industry.